This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: David Simpkin: Innovator in Influenza Vaccine Assays
Introduction
David Simpkin is a notable inventor based in Frodsham, GB. He has made significant contributions to the field of immunology, particularly in the development of assays for adsorbed influenza vaccines. His innovative approach has the potential to enhance the accuracy of vaccine testing.
Latest Patents
David holds a patent for "Assays for adsorbed influenza vaccines." This invention addresses the challenge that influenza hemagglutinin (HA) binds to aluminum salt adjuvants, making it difficult to assay directly using a single radial immunodiffusion (SRID) test. His modification of the SRID protocol includes a crucial step where the antigen is desorbed prior to diffusion, improving the assay's effectiveness.
Career Highlights
David Simpkin is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field, further advancing vaccine research and development.
Collaborations
Some of David's notable coworkers include Philip J Sizer and Jane King-Haughey. Their collective expertise contributes to the innovative environment at Novartis AG.
Conclusion
David Simpkin's contributions to the field of influenza vaccine assays exemplify the importance of innovation in healthcare. His patent and collaborative efforts highlight the ongoing advancements in vaccine research.